Loading clinical trials...
Loading clinical trials...
In the present study, we aim to investigate the effects of dobutamine infusion and/or a single intravenous (IV) dose of the IL-6 antagonist Tocilizumab administered after percutaneous coronary interve...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rigshospitalet, Denmark
Collaborators
NCT06710184 · NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Acute Myocardial Infarction (AMI)
NCT06638268 · Aortic Stenosis, Cardiogenic Shock
NCT04295252 · Cardiogenic Shock
NCT05604131 · Acute Myocardial Infarction Type 1
NCT07515508 · Cardiogenic Shock, Acute Heart Failure (AHF)
Rigshospitalet, Copenhagen University Hospital
Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions